Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
15/06/2026
European Central Bank President Lagarde: US-Iran agreement is good news.
Latest
1 m ago
DaYe Group: Zhucheng DaYe 200MW Wind Power Project Completed and Put into Operation
2 m ago
Takamichi Sanae: It is crucial to strictly implement the US-Iran agreement.
2 m ago
Li Hanqiong has been appointed as the chairman of Yageer Group.
3 m ago
Takashi Haya: Will issue a joint statement with the UK and other parties.
3 m ago
Merck (MRK.N) announced that its long-acting monoclonal antibody Clevrovimab injection (trade name: Anfuchang) has recently been approved by the China National Medical Products Administration for the prevention of lower respiratory tract infections caused by respiratory syncytial virus (RSV) in newborns and infants entering or born in the first RSV epidemic season.
See all latest